Life Extension

View more issues:

Articles in Nov, 2008 issue of Life Extension

• Dangers of excess estrogen in the aging male
  by William Faloon
• Brain food
  by Dayna Dye
• Higher plasma vitamin C levels linked with reduced diabetes risk
  by Dayna Dye
• Common spices help inhibit AGE
  by Dayna Dye
• Poor vitamin D status linked with greater eight-year mortality risk
  by Dayna Dye
• High omega-3 diet linked with lower heart disease risk
  by Dayna Dye
• Wonder drugs may treat many conditions
  by Dayna Dye
• Nutrient combination improves memory and learning
  by Michael J. Hall
• Soy isoflavones, curcumin synergize to thwart pancreatic cancer
  by Dale Kiefer
• Lycopene lowers lipids, slows accumulation of atherosclerotic plaque
  by Laura J. Ninger
• Resveratrol slows aging in mice
  by Laura J. Ninger
• Broccoli reduces prostate cancer risk
  by Dale Kiefer
• Pomegranate extract inhibits inflammation
  by Laura J. Ninger
• Calorie restriction decreases oxidative stress, increases life span
  by Dale Kiefer
• A breakthrough in the relief of overactive bladder and urinary incontinence
  by William Faloon
• Detect your risk of sudden heart attack and stroke
  by Laurie Barclay
• Regenerative medicine breakthroughs: will BioTime reset the clock of aging?
  by Julius Goepp
• Preventing cardiovascular disease naturally
  by Julius Goepp
• Apple stem cells offer hope for aging and damaged skin
  by Gary Goldfaden
• Marrow cell therapies for cardiovascular diseases
• Induced pluripotent stem cells generated from patients with als can be differentiated into motor neurons
• Stem cell treatment in amyotrophic lateral sclerosis
• In vitro generation of a scaffold-free tissue-engineered construct derived from human synovial mesenchymal stem cells: biological and mechanical properties, and further chondrogenic potential
• Chondrogenesis from immortalized human mesenchymal stem cells: comparison between collagen gel and pellet culture methods
• Stem-cell based therapies for brain tumors
• Disease-specific induced pluripotent stem cells
• The problem of deception in embryonic stem cell research
• Stem cell research: cloning, therapy and scientific fraud
• Human cloning and stem cell research: engaging in the political process
• Identifying the vulnerable patient with rupture-prone plaque
• The molecular basis of vulnerable plaque: potential therapeutic role for immunomodulation
• Enhanced expression of LP-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques
• Lipoprotein-associated phospholipase A2: A risk marker or a risk factor?
• Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention
• Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the rancho bernardo study
• Lipoprotein-associated phospholipase A2 and risk of stroke
• Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the atherosclerosis risk in communities study
• Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients
• Association of lipoprotein-associated phospholipase A2 with coronary calcification among American and Japanese men
• Current antiplatelet therapies: benefits and limitations
• Variability in response to cardiovascular drugs
• Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events
• The significance of low HDL-cholesterol levels in an ageing society at increased risk for cardiovascular disease
• Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence
• Anti-inflammatory agents and antioxidants as a possible "third great wave" in cardiovascular secondary prevention
• Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis
• Regulation of smooth muscle cells in development and vascular disease: current therapeutic strategies
• Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences
• Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system
• Estrogens and vascular thrombosis
• Serum estradiol and risk of stroke in elderly men
• Estradiol in elderly men
• Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. the MrOS study in Sweden
• Endogenous sex hormones and C-reactive protein in healthy postmenopausal women
• A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver
• Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture
• The role of estrogens and estrogen receptors in normal prostate growth and disease
• Important functions of estrogens in men—breakthrough in contemporary medicine
• Estrogens and bone health in men
• Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham study